Clinical Trial Update: Comparing Concomitant Use of ACell MicroMatrix® and ACell Cytal™ to Standard of Care in Stage 3 or 4 Pressure Injuries [NA]

View source ↗

Summary

Completed clinical trial comparing ACell MicroMatrix and ACell Cytal to standard of care for stage III/IV pressure ulcers; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pressure Ulcers

Drugs mentioned

• ACell Cytal (ACell Cytal)
• ACell MicroMatrix (ACell MicroMatrix)

Snippet

Sponsor: Integra LifeSciences Corporation | Conditions: Pressure Ulcers Stage III, Pressure Ulcer, Stage IV | NA | Status: COMPLETED | Results posted: 2020-11-16